# Bristol-Myers Squibb Company (BMY) — Q1-2018 Earnings Results

**Report date:** 2018-04-26 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q1-2018

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Up 0.54%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.94 | N/A | +10.46% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in the company's strategic direction. They emphasized the importance of innovation and maintaining a strong pipeline.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They noted ongoing investments in research and development to drive future growth.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report shows a solid EPS beat, which contributed to a slight increase in stock price. The positive surprise indicates that the company is performing better than expected in terms of profitability. However, the lack of revenue data and guidance leaves some uncertainty about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q1-2018_